Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Banyu Pharmaceutical discloses new DGAT-1 inhibitors

Sep. 8, 2010

NC-2500 is selected for clinical development in gout-related hyperuricemia

Sep. 7, 2010

Banyu Pharmaceutical discloses novel inhibitors of MGAT2

Sep. 7, 2010

GSK responds to article on rosiglitazone

Sep. 7, 2010

Levitra orodispersible tablet is approved in Europe for erectile dysfunction

Sep. 6, 2010

MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain

Sep. 6, 2010

Eisai launches Glufast in China for type 2 diabetes

Sep. 6, 2010

INT-007 is bioequivalent to branded tablet for erectile dysfunction

Sep. 6, 2010

New MCH1 receptor antagonists claimed by sanofi-aventis

Sep. 6, 2010

Orexigen and Takeda to co-commercialize Contrave in North America

Sep. 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...